Medical Equipment

In Vitro Diagnostics Market Analysis 2025–2029: Growth Forecast and Competitive Insights

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the in vitro diagnostics market from 2025–2034 with trusted insights from The Business Research Company

How Much Will The In Vitro Diagnostics Market Be Worth By 2029, And What CAGR Will It Achieve?

The in vitro diagnostics market has experienced rapid expansion in recent years. This market is expected to expand from $121.96 billion in 2024 to reach $136.55 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 12.0%. Factors contributing to its past expansion include the development of automated analyzers and molecular diagnostics, an aging population, instances of disease outbreaks, evolving healthcare regulations, and the progress of personalized medicine.

The in vitro diagnostics market is projected to undergo substantial expansion in the coming years. Its valuation is set to reach $214.88 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 12.0%. This anticipated growth during the forecast period is driven by developments in precision medicine, point-of-care testing, digital health and data analytics, and increased pandemic preparedness. Significant trends expected during this period involve technological advancements, the integration of digital health, personalized diagnostics, the availability of home testing kits, and molecular diagnostics.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

Which Factors Are Driving The In Vitro Diagnostics Market Forward?

The increasing adoption of self-administered test kits is projected to fuel the expansion of the in vitro diagnostics market moving ahead. These kits are defined as medical or diagnostic tools specifically created for personal use, allowing individuals to conduct tests independently at home without the involvement of healthcare professionals or trained staff. Such kits enhance ease of access by empowering people to perform diagnostic assessments from their residences, thereby offering convenience and potentially stimulating greater demand for testing, especially for conditions that have gone unnoticed. A notable instance illustrating this trend occurred in April 2022, where the Centers for Disease Control and Prevention, a US-based national public health agency, reported a substantial increase in at-home COVID-19 test utilization among U.S. adults aged 18 and older. This surge was observed from the Delta-predominant period (August to December 2021) to the Omicron-predominant period (December to March 2022). Specifically, the proportion of respondents experiencing COVID-19-like symptoms who opted for at-home tests grew from 5.7% to 20.1%. Consequently, the growing favorability of self-administered test kits will serve as a key driver for the in vitro diagnostics market’s advancement.

Which Segments Form The Key Structure Of The In Vitro Diagnostics Market?

The in vitro diagnosticsmarket covered in this report is segmented –

1) By Type: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment

2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

3) By Type of Expenditure: Public, Private

4) By Product: Instruments/Equipment, Disposables

Subsegments:

1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing

2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)

3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing

4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices

5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems

6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers

7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters

8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

How Are Global Trends Impacting The Development Of The In Vitro Diagnostics Market?

Leading firms active in the in vitro diagnostics market are concentrating on creating novel products, like the Cobas pulse system, aiming to boost their market profitability. This Cobas pulse system serves as a specialized blood glucose management solution, incorporating mobile digital health features to enhance patient care. As an example, in January 2022, Roche Diagnostics, a US-based company known for developing innovative products and services covering disease prevention, diagnosis, monitoring, screening, and treatment, introduced the Cobas pulse system. The Cobas pulse system itself is a portable instrument outfitted with an automated glucose test strip reader, a camera, and a touchscreen, facilitating the recording of extra diagnostic information. Its intuitive interface is engineered for simple deployment, offering practical functions that optimize processes, conserve time, and improve operational workflows.

Which Firms Are Making The Biggest Impact In The In Vitro Diagnostics Market?

Major companies operating in the in vitro diagnostics market include Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Which Region Is Expected To Lead The In Vitro Diagnostics Market In The Next Few Years?

North America was the largest region in the global in-vitro diagnostics market in 2024. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=13065&type=smp

Browse Through More Reports Similar to the Global In Vitro Diagnostics Market 2025, By The Business Research Company

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-monitoring-and-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795